Merck

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Merck 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRK

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. 

CEO
Robert M. Davis
CEORobert M. Davis
Employees
75,000
Employees75,000
Headquarters
Rahway, New Jersey
HeadquartersRahway, New Jersey
Founded
1891
Founded1891
Employees
75,000
Employees75,000

MRK Key Statistics

Market cap
357.67B
Market cap357.67B
Price-Earnings ratio
114.93
Price-Earnings ratio114.93
Dividend yield
2.34%
Dividend yield2.34%
Average volume
7.88M
Average volume7.88M
High today
$144.97
High today$144.97
Low today
$143.50
Low today$143.50
Open price
$143.50
Open price$143.50
Volume
7.23M
Volume7.23M
52 Week high
$156.92
52 Week high$156.92
52 Week low
$77.58
52 Week low$77.58

Stock Snapshot

Merck(MRK) stock is priced at $144.77, giving the company a market capitalization of 357.67B. It carries a P/E multiple of 114.93 and pays a dividend yield of 2.34%.

On 2026-09-16, Merck(MRK) stock moved within a range of $143.50 to $144.97. With shares now at $144.77, the stock is trading +0.9% above its intraday low and -0.1% below the session's peak.

Trading volume for Merck(MRK) stock has reached 7.23M, versus its average volume of 7.88M.

The stock's 52-week range extends from a low of $77.58 to a high of $156.92.

The stock's 52-week range extends from a low of $77.58 to a high of $156.92.

MRK News

Benzinga 12h
Here’s How Much You Would Have Made Owning Merck & Co Stock In The Last 5 Years - Benzinga

...

Here’s How Much You Would Have Made Owning Merck & Co Stock In The Last 5 Years - Benzinga
Simply Wall St 18h
Merck Expands Keytruda Trial Reach, Is 4% Undervalued Enough?

Merck (MRK) just expanded its oncology footprint by agreeing to supply Keytruda for Perspective Therapeutics’ trial that combines targeted alpha therapy [212Pb]...

Merck Expands Keytruda Trial Reach, Is 4% Undervalued Enough?
24/7 Wall St. 2d
Eli Lilly Vs. Merck: One is a No-Brainer to Hold Through 2030

Investing Eli Lilly Vs. Merck: One is a No-Brainer to Hold Through 2030 Eli Lilly and Merck both reported second quarter earnings, and the contrast could not be...

Eli Lilly Vs. Merck: One is a No-Brainer to Hold Through 2030

Analyst ratings

68%

of 31 ratings
Buy
67.7%
Hold
29%
Sell
3.2%

More MRK News

TipRanks 3d
Perspective Therapeutics announces trial collaboration agreement with Merck

Perspective Therapeutics (CATX) announced a clinical trial collaboration agreement with Merck (MRK). The agreement supports the evaluation of Perspective’s targ...

Seeking Alpha 3d
Summit’s ivonescimab cuts death risk by 27% versus Keytruda in lung cancer trial

Summit Therapeutics (SMMT) on Sunday said ivonescimab significantly extended survival compared with Merck’s (MRK) Keytruda in a late-stage lung cancer trial con...

Summit’s ivonescimab cuts death risk by 27% versus Keytruda in lung cancer trial
TipRanks 4d
Schwab US Dividend Equity ETF Sees Inflows Amid Weak Performance

Schwab US Dividend Equity ETF ( $SCHD ) has fallen by 1.95% in the past week. It has experienced a 5-day net inflow of $710.9 million. This is due, in part, to...

24/7 Wall St. 5d
Moderna Rallies 8% on 2026 Melt-Up Momentum Even While BioNTech and Merck Stay Flat

Investing Moderna Rallies 8% on 2026 Melt-Up Momentum Even While BioNTech and Merck Stay Flat Moderna just surged 8% on a morning when its closest cancer-vaccin...

Moderna Rallies 8% on 2026 Melt-Up Momentum Even While BioNTech and Merck Stay Flat

People also own

Based on the portfolios of people who own MRK. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.